MedTrace Logo

CE-STAND: Cervical Epidural STimulation After Neurologic Damage

NCT06410001 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-03-27

No results posted yet for this study

Summary

CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.

Conditions

  • Spinal Cord Injury

Interventions

DEVICE

Epidural Spinal Cord Stimulation System

Abbott Eterna system implantable pulse generator (IPG), charger, and TriCentrus lead

Sponsors & Collaborators

Principal Investigators

  • Ann Parr, MD, PhD · University of Minnesota

  • Manda Keller-Ross, PhD, DPT, PT · University of Minnesota

  • Nadine Mansour, MD, MPH, PhD · University of Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2030-05-31
Completion
2030-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06410001 on ClinicalTrials.gov